Send the following on WhatsApp
Continue to ChatHere is Eli Lilly's competitive edge in GLP-1 obesity drugs and Abbott's secondary play https://democraticvoiceusa.com/2024/03/03/here-is-eli-lillys-competitive-edge-in-glp-1-obesity-drugs-and-abbotts-secondary-play/